Thami Sebti

460 total citations
13 papers, 391 citations indexed

About

Thami Sebti is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Infectious Diseases. According to data from OpenAlex, Thami Sebti has authored 13 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Pharmaceutical Science and 2 papers in Infectious Diseases. Recurrent topics in Thami Sebti's work include Inhalation and Respiratory Drug Delivery (12 papers), Drug Solubulity and Delivery Systems (3 papers) and Cystic Fibrosis Research Advances (3 papers). Thami Sebti is often cited by papers focused on Inhalation and Respiratory Drug Delivery (12 papers), Drug Solubulity and Delivery Systems (3 papers) and Cystic Fibrosis Research Advances (3 papers). Thami Sebti collaborates with scholars based in Belgium, United States and France. Thami Sebti's co-authors include Karim Amighi, Gabrielle Pilcer, Francis Vanderbist, Nathalie Wauthoz, Christophe Duret, Karl Traina, Christophe Duret, Rémi Rosière, Isabelle Roland and Calliope Maris and has published in prestigious journals such as The Journal of Immunology, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Thami Sebti

13 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thami Sebti Belgium	10	312	188	114	45	39	13	391
Nasser Alhajj Ireland	8	237 0.8×	141 0.8×	118 1.0×	22 0.5×	42 1.1×	11	360
Nivedita Shetty United States	9	380 1.2×	182 1.0×	178 1.6×	35 0.8×	43 1.1×	12	459
Donghao Chen Australia	7	441 1.4×	206 1.1×	203 1.8×	43 1.0×	55 1.4×	9	501
Timothy M. Crowder United States	10	298 1.0×	177 0.9×	135 1.2×	22 0.5×	66 1.7×	15	493
Priya Muralidharan United States	9	335 1.1×	153 0.8×	54 0.5×	71 1.6×	59 1.5×	16	440
Tristan P. Learoyd United Kingdom	7	359 1.2×	270 1.4×	199 1.7×	34 0.8×	44 1.1×	7	456
Ashlee D. Brunaugh United States	12	203 0.7×	166 0.9×	84 0.7×	37 0.8×	113 2.9×	16	420
Poonam Sheth United States	11	339 1.1×	253 1.3×	75 0.7×	93 2.1×	24 0.6×	18	585
Yoen‐Ju Son United States	15	645 2.1×	225 1.2×	175 1.5×	98 2.2×	34 0.9×	19	717
Marcel Hoppentocht Netherlands	7	574 1.8×	168 0.9×	173 1.5×	115 2.6×	31 0.8×	9	623

Countries citing papers authored by Thami Sebti

Since Specialization

Citations

This map shows the geographic impact of Thami Sebti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thami Sebti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thami Sebti more than expected).

Fields of papers citing papers by Thami Sebti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thami Sebti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thami Sebti. The network helps show where Thami Sebti may publish in the future.

Co-authorship network of co-authors of Thami Sebti

This figure shows the co-authorship network connecting the top 25 collaborators of Thami Sebti. A scholar is included among the top collaborators of Thami Sebti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thami Sebti. Thami Sebti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pauw, Pieter De, Steve Schoonooghe, Cédric Delporte, et al.. (2021). Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead Optimization. The Journal of Immunology. 207(10). 2608–2620. 7 indexed citations

Wauthoz, Nathalie, et al.. (2016). Optimization and scaling-up of ITZ-based dry powders for inhalation. Journal of Drug Delivery Science and Technology. 37. 147–157. 7 indexed citations

Pilcer, Gabrielle, Rémi Rosière, Karl Traina, et al.. (2013). New Co-Spray-Dried Tobramycin Nanoparticles-Clarithromycin Inhaled Powder Systems for Lung Infection Therapy in Cystic Fibrosis Patients. Journal of Pharmaceutical Sciences. 102(6). 1836–1846. 38 indexed citations

Pilcer, Gabrielle, Karl Traina, Hamidou Traore, et al.. (2013). Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis. International Journal of Pharmaceutics. 451(1-2). 112–120. 27 indexed citations

Duret, Christophe, Nathalie Wauthoz, Rémi Rosière, et al.. (2013). Prophylactic Efficacy of Inhaled Itraconazole-Mannitol Dried Solid Dispersion Against Invasive Pulmonary Aspergillosis. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 383–388. 1 indexed citations

Duret, Christophe, et al.. (2013). Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention. European Journal of Pharmaceutics and Biopharmaceutics. 86(1). 46–54. 23 indexed citations

Duret, Christophe, Nathalie Wauthoz, Jonathan Goole, et al.. (2012). In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. European Journal of Pharmaceutics and Biopharmaceutics. 81(3). 627–634. 41 indexed citations

Duret, Christophe, Nathalie Wauthoz, Thami Sebti, Francis Vanderbist, & Karim Amighi. (2012). Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties. International Journal of Pharmaceutics. 428(1-2). 103–113. 58 indexed citations

Duret, Christophe, Nathalie Wauthoz, Thami Sebti, Francis Vanderbist, & Karim Amighi. (2012). New Respirable and Fast Dissolving Itraconazole Dry Powder Composition for the Treatment of Invasive Pulmonary Aspergillosis. Pharmaceutical Research. 29(10). 2845–2859. 17 indexed citations

10.

Sebti, Thami, Francis Vanderbist, & Karim Amighi. (2007). Evaluation of the content homogeneity and dispersion properties of fluticasone DPI compositions. Journal of Drug Delivery Science and Technology. 17(3). 223–229. 9 indexed citations

11.

Pilcer, Gabrielle, Thami Sebti, & Karim Amighi. (2006). Formulation and Characterization of Lipid-Coated Tobramycin Particles for Dry Powder Inhalation. Pharmaceutical Research. 23(5). 931–940. 85 indexed citations

12.

Sebti, Thami, Gabrielle Pilcer, Serge Goldman, et al.. (2006). Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation. European Journal of Pharmaceutics and Biopharmaceutics. 64(1). 26–32. 13 indexed citations

13.

Sebti, Thami & Karim Amighi. (2005). Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. European Journal of Pharmaceutics and Biopharmaceutics. 63(1). 51–58. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact